Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Clinical observation of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy of malignant blood disease
  
View Full Text  View/Add Comment  Download reader
KeyWord:
Author NameAffiliation
Bei-bei Yue The First People’s Hospital of Shashi, 434000, Hubei 
Le-san Xia The First People’s Hospital of Shashi, 434000, Hubei 
Cheng-tai Yuan The First People’s Hospital of Shashi, 434000, Hubei 
Qing Wu The First People’s Hospital of Shashi, 434000, Hubei 
Ming-qing Xiang The First People’s Hospital of Shashi, 434000, Hubei 
Shao-kun Dong The First People’s Hospital of Shashi, 434000, Hubei 
Zheng-ju Zhou The First People’s Hospital of Shashi, 434000, Hubei 
Hits: 1174
Download times: 878
Abstract:
      The use of high dose cinobufocini in attenuation and treatment of infection and granulocytopenia during combined chemotherapy was observed in patients with malignant blood diseases. The study was designed in such a way that each patient served also as part of the control group. The test group included 18 males and 12 females, ranged in ages between 16 and 66 (averaged 34). Sixty-two experiments were run on 20 patients with acute leukemia, 8 with malignant lymphoma and 2 with multiple myeloma. The test group was treated with high dosages of cinobufocini. In each case, instances of infection were significantly decreased and the number of granulocytes was not markedly changed by the treatment. The results of this study suggest that high dosage cinobufocini therapy may significantly reduce the risk of infection and the degree and duration of granulocytopenia associated with chemotherapy for malignant blood diseases. Also, high dosage cinobufocini therapy is simple, convenient and causes little or no side effects.
Close